| Ashley Ann Higgins, MSN, ARNP | |
|
400 E 3rd St, Elk City, OK 73644 | |
| (580) 225-1173 | |
| Not Available |
| Full Name | Ashley Ann Higgins |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Family |
| Location | 400 E 3rd St, Elk City, Oklahoma |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1619281268 | NPI | - | NPPES |
| 200335490A | Medicaid | OK |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 82852 (Oklahoma) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ashley Ann Higgins, MSN, ARNP 400 E 3rd St, Elk City, OK 73644-4720 Ph: (580) 225-1173 | Ashley Ann Higgins, MSN, ARNP 400 E 3rd St, Elk City, OK 73644 Ph: (580) 225-1173 |
News Archive
Genzyme Corp. and Isis Pharmaceuticals Inc. announced that data from the phase 3 study of mipomersen in patients with heterozygous familial hypercholesterolemia (heFH) were presented today at the European Society of Cardiology's Congress 2010 in Stockholm, Sweden. The study met its primary endpoint with a 28 percent reduction in LDL-cholesterol, compared with an increase of 5 percent for placebo (p<0.001). The trial also met all of its secondary and tertiary endpoints.
Duke University Medical Center researchers have used imaging technology to identify a new marker that may help identify those at greatest risk for cognitive decline and the development of Alzheimer's disease.
Reduced volume, or atrophy, in parts of the brain known as the amygdala and hippocampus may predict which cognitively healthy elderly people will develop dementia over a six-year period, according to a study in the January issue of Archives of General Psychiatry, one of the JAMA/Archives journals.
Researchers in Australia, Denmark, and the United States have conducted a study showing the extent to which community testing, contact tracing, and mask-wearing can lower the transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the Australian state of New South Wales.
Teva Pharmaceutical Industries Ltd. and APP Pharmaceuticals, Inc. announced today the commercial launch of Gemcitabine HCI for Injection in 200 mg and 1 g single dose vials, the generic version of Gemzar®, in the United States, pursuant to a commercialization, manufacture and supply agreement signed by the two companies.
› Verified 2 days ago
Jacob Jackson, APRN, CNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1800 W 1st St Ste 105b, Elk City, OK 73644 Phone: 580-225-2518 Fax: 580-225-3167 | |
Kasee Mcarthur, APRN C-NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 411 N Randall Ave, Elk City, OK 73644 Phone: 580-243-2273 | |
Alicia K Price, NP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1710 W 3rd St, Elk City, OK 73644 Phone: 580-225-1290 Fax: 580-225-2178 | |
Amanda Lynn Lafarlette, APRNC-NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 411 N Randall Ave, Elk City, OK 73644 Phone: 580-243-2273 Fax: 580-243-2832 | |
Joy Celsor, APRN, FNP-BC, FNP-C Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 209 S Jefferson Ave, Elk City, OK 73644 Phone: 580-799-5471 | |
Rubi Ann Litteral, APRN-CNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 411 W 3rd St, Elk City, OK 73644 Phone: 580-303-9293 Fax: 580-540-3017 | |
Katie Jane Robinson, NP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2406 Bell Ave, Elk City, OK 73644 Phone: 580-303-7944 Fax: 580-210-5227 |